TransMedics (TMDX) Long-Term Deferred Tax (2025 - 2026)
TransMedics (TMDX) posted quarterly Long-Term Deferred Tax of $82.5 million for Q1 2026, down 1.28% quarter-over-quarter from $83.5 million in Q4 2025.
TransMedics (TMDX) Long-Term Deferred Tax (2025 - 2026) Analysis & Trends
TransMedics' Long-Term Deferred Tax history runs 2 years deep, the most recent figure standing at $82.5 million for Q1 2026.
- In Q1 2026, Long-Term Deferred Tax changed N/A year-over-year to $82.5 million; the TTM figure through Mar 2026 stood at $82.5 million (changed N/A YoY), while the FY2025 annual figure was $83.5 million, changed N/A from the prior year.
- Long-Term Deferred Tax for Q1 2026 stood at $82.5 million, down from $83.5 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $83.5 million in Q4 2025, with the low at $82.5 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | TransMedics | 3.15 Bn | 2.67 Bn | 113.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 78.68 Mn |
| Mar 31, 2026 | 82.48 Mn |
| Dec 31, 2025 | 83.54 Mn |